Short term outcomes of Impella circulatory support for high‐risk percutaneous coronary intervention a systematic review and meta‐analysis
- 24 May 2021
- journal article
- review article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (1) , 27-36
Abstract
Objective: Aim of this study is to evaluate short term safety and efficacy of Impella in high risk percutaneous coronary intervention (HR‐PCI) population.Background: While several studies demonstrated the clinical significance of Impella in HR‐PCI, few data exist about its impact on short term outcome.Methods: All studies reporting short term outcomes of PCI with any Impella device were included. The primary endpoint was either in‐hospital or 30‐day mortality, while vascular complications, post‐procedural stroke, post‐procedural dialysis and bleeding complications were assessed as secondary outcomes.Results: Nine studies with 7448 patients were included. Median age was 69.5 years old (67–73), with a mean ejection fraction of 29.7% (20%–39%) and a Syntax score of 30.2 (25. 5–33, interquartile [IQR]). Impella 2.5 was the most commonly used axial flow pump used to support these PCIs (88.7%). In‐hospital death was observed in 5.09% of patients (95% confidence interval [CI] 3.69–6.49, I2 = 78%), while vascular complications in 2.53% of patients (1.07–4.00, I2 = 89%) and post‐procedural stroke in 2.77% of patients (0.50–6.05, I2 = 98%). Major bleeding occurred in 5.98% of patients (3.66–8.31, I2 = 90%) and post‐procedural dialysis in 4.44% of patients (1.50–7.37, I2 = 93% all CI 93%).Conclusion: Use of Impella in high risk PCI appears to have an acceptable rate of complication, especially regarding vascular complications and major bleedings.Keywords
This publication has 19 references indexed in Scilit:
- The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular FunctionThe American Journal of Cardiology, 2018
- The effectiveness and safety of the Impella ventricular assist device for high‐risk percutaneous coronary interventions: A systematic reviewCatheterization and Cardiovascular Interventions, 2017
- Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patientsEuropean Heart Journal, 2017
- Meta-Analysis of Usefulness of Percutaneous Left Ventricular Assist Devices for High-Risk Percutaneous Coronary InterventionsThe American Journal of Cardiology, 2016
- Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: A comprehensive meta-analysis of randomised trials and observational studiesInternational Journal of Cardiology, 2013
- A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary InterventionCirculation, 2012
- Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary interventionCardiovascular Revascularization Medicine, 2011
- Elective Intra-aortic Balloon Counterpulsation During High-Risk Percutaneous Coronary InterventionA Randomized Controlled TrialJAMA, 2010
- Supported High-Risk Percutaneous Coronary Intervention With the Impella 2.5 DeviceJACC, 2009
- Effects of mechanical left ventricular unloading by impella on left ventricular dynamics in high‐risk and primary percutaneous coronary intervention patientsCatheterization and Cardiovascular Interventions, 2009